A nutraceutical approach (armolipid plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: review of the clinical evidence
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Amsterdam ; Boston ; London ; New York ; Oxford ; Paris ; Philadelphia ; San Diego ; St. Louis
Elsevier
[2017]
|
Schriftenreihe: | Atherosclerosis. Supplements
volume 24 (February 2017) |
Beschreibung: | 15 Seiten Diagramme |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV044361996 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 170621s2017 |||| |||| 00||| eng d | ||
035 | |a (OCoLC)992463888 | ||
035 | |a (DE-599)BVBBV044361996 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-19 | ||
100 | 1 | |a Barrios, Vivencio |e Verfasser |0 (DE-588)1135671397 |4 aut | |
245 | 1 | 0 | |a A nutraceutical approach (armolipid plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia |b review of the clinical evidence |c Vivencio Barrios, Carlos Escobar, Arrigo Francesco Giuseppe Cicero, David Burke, Peter Fasching, Maciej Banach, Eric Bruckert |
264 | 1 | |a Amsterdam ; Boston ; London ; New York ; Oxford ; Paris ; Philadelphia ; San Diego ; St. Louis |b Elsevier |c [2017] | |
300 | |a 15 Seiten |b Diagramme | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Atherosclerosis. Supplements |v volume 24 (February 2017) | |
700 | 1 | |a Escobar, Carlos |e Verfasser |0 (DE-588)1135671508 |4 aut | |
700 | 1 | |a Cicero, Arrigo F. G. |e Verfasser |4 aut | |
700 | 1 | |a Burke, David |e Verfasser |4 aut | |
700 | 1 | |a Fasching, Peter |d 1963- |e Verfasser |0 (DE-588)120632764 |4 aut | |
700 | 1 | |a Banach, Maciej |e Verfasser |4 aut | |
700 | 1 | |a Bruckert, Eric |e Verfasser |4 aut | |
830 | 0 | |a Atherosclerosis. Supplements |v volume 24 (February 2017) |w (DE-604)BV013391023 |9 24 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-029764625 |
Datensatz im Suchindex
_version_ | 1804177610749509632 |
---|---|
any_adam_object | |
author | Barrios, Vivencio Escobar, Carlos Cicero, Arrigo F. G. Burke, David Fasching, Peter 1963- Banach, Maciej Bruckert, Eric |
author_GND | (DE-588)1135671397 (DE-588)1135671508 (DE-588)120632764 |
author_facet | Barrios, Vivencio Escobar, Carlos Cicero, Arrigo F. G. Burke, David Fasching, Peter 1963- Banach, Maciej Bruckert, Eric |
author_role | aut aut aut aut aut aut aut |
author_sort | Barrios, Vivencio |
author_variant | v b vb c e ce a f g c afg afgc d b db p f pf m b mb e b eb |
building | Verbundindex |
bvnumber | BV044361996 |
ctrlnum | (OCoLC)992463888 (DE-599)BVBBV044361996 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01503nam a2200337 cb4500</leader><controlfield tag="001">BV044361996</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">170621s2017 |||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)992463888</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044361996</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Barrios, Vivencio</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1135671397</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A nutraceutical approach (armolipid plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia</subfield><subfield code="b">review of the clinical evidence</subfield><subfield code="c">Vivencio Barrios, Carlos Escobar, Arrigo Francesco Giuseppe Cicero, David Burke, Peter Fasching, Maciej Banach, Eric Bruckert</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam ; Boston ; London ; New York ; Oxford ; Paris ; Philadelphia ; San Diego ; St. Louis</subfield><subfield code="b">Elsevier</subfield><subfield code="c">[2017]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">15 Seiten</subfield><subfield code="b">Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Atherosclerosis. Supplements</subfield><subfield code="v">volume 24 (February 2017)</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Escobar, Carlos</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1135671508</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cicero, Arrigo F. G.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burke, David</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fasching, Peter</subfield><subfield code="d">1963-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)120632764</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Banach, Maciej</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bruckert, Eric</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Atherosclerosis. Supplements</subfield><subfield code="v">volume 24 (February 2017)</subfield><subfield code="w">(DE-604)BV013391023</subfield><subfield code="9">24</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029764625</subfield></datafield></record></collection> |
id | DE-604.BV044361996 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:50:49Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029764625 |
oclc_num | 992463888 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM |
owner_facet | DE-19 DE-BY-UBM |
physical | 15 Seiten Diagramme |
publishDate | 2017 |
publishDateSearch | 2017 |
publishDateSort | 2017 |
publisher | Elsevier |
record_format | marc |
series | Atherosclerosis. Supplements |
series2 | Atherosclerosis. Supplements |
spelling | Barrios, Vivencio Verfasser (DE-588)1135671397 aut A nutraceutical approach (armolipid plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia review of the clinical evidence Vivencio Barrios, Carlos Escobar, Arrigo Francesco Giuseppe Cicero, David Burke, Peter Fasching, Maciej Banach, Eric Bruckert Amsterdam ; Boston ; London ; New York ; Oxford ; Paris ; Philadelphia ; San Diego ; St. Louis Elsevier [2017] 15 Seiten Diagramme txt rdacontent n rdamedia nc rdacarrier Atherosclerosis. Supplements volume 24 (February 2017) Escobar, Carlos Verfasser (DE-588)1135671508 aut Cicero, Arrigo F. G. Verfasser aut Burke, David Verfasser aut Fasching, Peter 1963- Verfasser (DE-588)120632764 aut Banach, Maciej Verfasser aut Bruckert, Eric Verfasser aut Atherosclerosis. Supplements volume 24 (February 2017) (DE-604)BV013391023 24 |
spellingShingle | Barrios, Vivencio Escobar, Carlos Cicero, Arrigo F. G. Burke, David Fasching, Peter 1963- Banach, Maciej Bruckert, Eric A nutraceutical approach (armolipid plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia review of the clinical evidence Atherosclerosis. Supplements |
title | A nutraceutical approach (armolipid plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia review of the clinical evidence |
title_auth | A nutraceutical approach (armolipid plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia review of the clinical evidence |
title_exact_search | A nutraceutical approach (armolipid plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia review of the clinical evidence |
title_full | A nutraceutical approach (armolipid plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia review of the clinical evidence Vivencio Barrios, Carlos Escobar, Arrigo Francesco Giuseppe Cicero, David Burke, Peter Fasching, Maciej Banach, Eric Bruckert |
title_fullStr | A nutraceutical approach (armolipid plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia review of the clinical evidence Vivencio Barrios, Carlos Escobar, Arrigo Francesco Giuseppe Cicero, David Burke, Peter Fasching, Maciej Banach, Eric Bruckert |
title_full_unstemmed | A nutraceutical approach (armolipid plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia review of the clinical evidence Vivencio Barrios, Carlos Escobar, Arrigo Francesco Giuseppe Cicero, David Burke, Peter Fasching, Maciej Banach, Eric Bruckert |
title_short | A nutraceutical approach (armolipid plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia |
title_sort | a nutraceutical approach armolipid plus to reduce total and ldl cholesterol in individuals with mild to moderate dyslipidemia review of the clinical evidence |
title_sub | review of the clinical evidence |
volume_link | (DE-604)BV013391023 |
work_keys_str_mv | AT barriosvivencio anutraceuticalapproacharmolipidplustoreducetotalandldlcholesterolinindividualswithmildtomoderatedyslipidemiareviewoftheclinicalevidence AT escobarcarlos anutraceuticalapproacharmolipidplustoreducetotalandldlcholesterolinindividualswithmildtomoderatedyslipidemiareviewoftheclinicalevidence AT ciceroarrigofg anutraceuticalapproacharmolipidplustoreducetotalandldlcholesterolinindividualswithmildtomoderatedyslipidemiareviewoftheclinicalevidence AT burkedavid anutraceuticalapproacharmolipidplustoreducetotalandldlcholesterolinindividualswithmildtomoderatedyslipidemiareviewoftheclinicalevidence AT faschingpeter anutraceuticalapproacharmolipidplustoreducetotalandldlcholesterolinindividualswithmildtomoderatedyslipidemiareviewoftheclinicalevidence AT banachmaciej anutraceuticalapproacharmolipidplustoreducetotalandldlcholesterolinindividualswithmildtomoderatedyslipidemiareviewoftheclinicalevidence AT bruckerteric anutraceuticalapproacharmolipidplustoreducetotalandldlcholesterolinindividualswithmildtomoderatedyslipidemiareviewoftheclinicalevidence |